CHRS EBITDA | Coherus Oncology, Inc.

Coherus Oncology, Inc. (CHRS) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$32.33M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$36.15M; Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$45.58M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$44.03M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2012-12-31 to 2025-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$32.33M	(m)	(m)	(m)	(m)	-$62.09M*	$4.24M	$21.44M	$20.95M	(m)
2026-03-31	Reported	(m)	-$36.15M	(m)	(m)	(m)	(m)	-$57.89M	$3.81M	$21.54M	$23.10M	(m)
2025-12-31	Reported	-$45.58M	(m)	(m)	(m)	-357.55%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$44.03M	(m)	(m)	(m)	-380.55%	(m)	-$46.34M*	$3.72M	$27.25M	$24.93M	(m)
2025-06-30	Reported	-$45.19M	(m)	(m)	(m)	-440.67%	(m)	-$46.63M*	$3.40M	$26.31M	$26.04M	(m)
2025-03-31	Reported	-$45.04M	(m)	(m)	(m)	-592.64%	(m)	-$25.83M	$2.65M	$24.36M	$26.02M	(m)
2024-12-31	Reported	-$45.28M	(m)	(m)	(m)	-585.59%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$46.46M	(m)	(m)	(m)	-767.61%	(m)	-$62.02M*	$2.73M	$22.05M	$28.13M	(m)
2024-06-30	Reported	-$39.13M	(m)	(m)	(m)	-380.01%	(m)	$59.73M*	$1.81M	$20.60M	$27.52M	(m)
2024-03-31	Reported	-$67.19M	(m)	(m)	(m)	-2911.05%	(m)	-$46.77M	$1.44M	$28.42M	$40.23M	(m)
2023-12-31	Reported	-$68.21M	(m)	(m)	(m)	-74.52%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$31.21M	(m)	(m)	(m)	-41.85%	$0.00*	-$54.30M*	$32.70M	$25.65M	$48.22M	-$380.00K
2023-06-30	Reported	-$33.74M	(m)	(m)	(m)	-57.47%	$100.00K*	-$38.91M*	$24.85M	$23.27M	$45.14M	(m)
2023-03-31	Reported	-$66.85M	(m)	(m)	(m)	-206.08%	$152.00K	-$68.73M	$16.87M	$34.15M	$49.15M	(m)
2022-12-31	Reported	-$50.49M	(m)	(m)	(m)	-111.34%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$79.55M	(m)	(m)	(m)	-175.13%	$457.00K*	-$37.09M*	$35.23M	$45.81M	$44.83M	(m)
2022-06-30	Reported	-$43.11M	(m)	(m)	(m)	-71.67%	$880.00K*	-$50.04M*	$11.28M	$41.61M	$51.28M	(m)
2022-03-31	Reported	(m)	-$80.92M	(m)	(m)	(m)	$615.00K	-$54.05M	$9.37M	$82.92M	$48.75M	(m)
2021-09-30	Reported	(m)	-$32.79M	(m)	(m)	(m)	$261.00K*	$13.71M*	$21.28M	$54.09M	$39.92M	$0.00
2021-06-30	Reported	(m)	-$24.16M	(m)	(m)	(m)	$415.00K*	-$188.00K*	$16.70M	$54.77M	$40.34M	$0.00
2021-03-31	Reported	(m)	-$167.36M	(m)	(m)	(m)	$145.00K	$1.37M	$7.51M	$203.49M	$39.39M	$0.00
2020-09-30	Reported	(m)	$33.72M	(m)	(m)	(m)	$2.11M*	$47.35M*	$9.00M	$38.85M	$31.98M	$183.00K
2020-06-30	Reported	(m)	$65.31M	(m)	(m)	(m)	$2.38M*	$60.19M*	$10.14M	$26.17M	$34.05M	$1.29M
2020-03-31	Reported	(m)	$40.87M	(m)	(m)	(m)	$1.78M	$13.48M	$6.86M	$33.11M	$35.35M	$933.00K
2019-09-30	Reported	(m)	$51.84M	(m)	$111.68M	(m)	$918.00K*	$54.95M*	(m)	$21.57M	$31.83M	$847.00K
2019-06-30	Reported	(m)	$27.49M	(m)	$83.43M	(m)	$182.00K*	$12.68M*	$601.00K	$18.88M	$36.46M	$51.00K
2019-03-31	Reported	(m)	-$16.60M	(m)	$37.10M	(m)	$335.00K	-$56.98M	$2.23M	$18.79M	$32.68M	$0.00
2018-09-30	Reported	(m)	-$56.97M	(m)	$0.00	(m)	$489.00K*	-$42.79M*	(m)	$31.60M	$25.37M	$0.00
2018-06-30	Reported	(m)	-$44.91M	(m)	$0.00	(m)	$5.00K*	-$35.53M*	$0.00	$26.52M	$18.39M	$0.00
2018-03-31	Reported	(m)	-$42.03M	(m)	$0.00	(m)	$81.00K	-$33.58M	$0.00	$25.45M	$16.58M	(m)
2017-09-30	Reported	(m)	-$56.62M	(m)	$0.00	(m)	$1.81M*	-$41.51M*	(m)	$42.63M	(m)	(m)
2017-06-30	Reported	(m)	-$56.64M	(m)	$1.40M	(m)	$961.00K*	(m)	(m)	$34.50M	(m)	(m)
2017-03-31	Reported	(m)	-$72.42M	(m)	$161.00K	(m)	$1.69M	(m)	(m)	$53.77M	(m)	(m)
2016-09-30	Reported	(m)	$84.62M	(m)	(m)	(m)	$500.00K*	(m)	(m)	$64.57M	(m)	(m)
2016-06-30	Reported	(m)	-$62.74M	(m)	(m)	(m)	$301.00K*	(m)	(m)	$65.54M	(m)	(m)
2016-03-31	Reported	(m)	-$64.35M	(m)	(m)	(m)	$2.15M	(m)	(m)	$65.31M	(m)	(m)
2015-09-30	Reported	(m)	-$71.22M	(m)	(m)	(m)	$2.40M*	(m)	(m)	$68.22M	(m)	(m)
2015-06-30	Reported	-$58.5M	(m)	(m)	(m)	-851.95%	$1.01M*	(m)	(m)	$56.94M	(m)	(m)
2015-03-31	Reported	-$36.52M	(m)	(m)	(m)	-628.50%	$1.31M	(m)	(m)	$36.47M	(m)	(m)
2014-12-31	Reported	-$26.33M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$6.23M	(m)	(m)	(m)	(m)	$807.00K*	(m)	(m)	$18.50M	(m)	(m)
2014-06-30	Reported	-$17.81M	(m)	(m)	(m)	(m)	$1.29M*	(m)	(m)	$18.93M	(m)	(m)
2014-03-31	Reported	-$13.65M	(m)	(m)	(m)	(m)	$260.00K	(m)	(m)	$13.94M	(m)	(m)
2013-12-31	Reported	-$10.38M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$6.68M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$4.93M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$179.83M	(m)	(m)	(m)	-426.43%	(m)	-$138.51M	$13.81M	$108.89M	$100.60M	$0.00
2024-12-31	Reported	-$198.05M	(m)	(m)	(m)	-750.51%	(m)	-$20.44M	$8.73M	$91.83M	$125.48M	$0.00
2023-12-31	Reported	-$200M	(m)	(m)	(m)	-77.75%	$286.00K	-$174.88M	$438.00K	$96.11M	$120.46M	-$380.00K
2022-12-31	Reported	-$253.28M	(m)	(m)	(m)	-120.01%	$2.04M	-$241.12M	$70.08M	$199.36M	$198.48M	$0.00
2021-12-31	Reported	-$260.36M	(m)	(m)	(m)	-79.73%	$1.29M	-$37.43M	$57.59M	$363.11M	$169.71M	$0.00
2020-12-31	Reported	(m)	$156.32M	(m)	(m)	(m)	$7.23M	$154.15M	$37.67M	$142.76M	$139.08M	$3.46M
2019-12-31	Reported	(m)	$107.77M	(m)	(m)	(m)	$1.82M	$28.36M	$17.08M	$94.19M	$137.04M	$2.94M
2018-12-31	Reported	(m)	-$204.42M	(m)	$0.00	(m)	$789.00K	-$159.27M	(m)	$110.24M	$94.18M	$0.00
2017-12-31	Reported	(m)	-$232.14M	(m)	$1.56M	(m)	$4.57M	-$200.29M	(m)	$162.39M	$71.30M	$0.00
2016-12-31	Reported	(m)	-$115.93M	(m)	$189.48M	(m)	$6.51M	-$252.54M	(m)	$254.44M	$51.60M	$0.00
2015-12-31	Reported	(m)	-$219.07M	(m)	(m)	(m)	$6.16M	(m)	(m)	$213.06M	(m)	$0.00
2014-12-31	Reported	-$64.01M	(m)	(m)	(m)	-205.77%	$2.85M	(m)	(m)	$78.22M	(m)	$0.00
2013-12-31	Reported	-$35.59M	(m)	(m)	(m)	-1293.68%	$373.00K	(m)	(m)	$31.28M	(m)	(m)
2012-12-31	Reported	-$38.3M	(m)	(m)	(m)	-2016.69%	$1.78M	(m)	(m)	$34.89M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Alpha Cognition Inc. (ACOG)		$0.185B	-6.77
PRECISION BIOSCIENCES INC (DTIL)	United States	$0.175B	-3.95
Voyager Therapeutics, Inc. (VYGR)	United States	$0.173B	-1.99
Protara Therapeutics, Inc. (TARA)	United States	$0.198B	-3.22
Acumen Pharmaceuticals, Inc. (ABOS)	United States	$0.162B	-1.83
Outlook Therapeutics, Inc. (OTLK)	United States	$0.162B	-4.90
Compass Therapeutics, Inc. (CMPX)	United States	$0.204B	-5.35
Humacyte, Inc. (HUMA)	United States	$0.155B	-2.26
Alector, Inc. (ALEC)	United States	$0.213B	-1.90
ANAVEX LIFE SCIENCES CORP. (AVXL)	United States	$0.218B	-18.37